Concepedia

Tim Karl

TK

Statistics

Publications

92

Citations

5.3K

H-Index

45

Active since

2003

Affiliations

Neuroscience Research Australia(Current)

Schizophrenia Research Institute

UNSW Sydney

Western Sydney University

Garvan Institute of Medical Research

Tim Karl is an author at Neuroscience Research Australia specializing in neuroscience, life sciences, and molecular neuroscience.

ORCID

Publications per year

2003–2024

92

Publications

92

Deletion of<i>Abca7</i>Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease

Woojin S. Kim, Hongyun Li, Kalani Ruberu et al. · Journal of Neuroscience · 2013 · 206 citations · Full text

, , +17

A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

Leonora E. Long, Rose Chesworth, Xu‐Feng Huang et al. · The International Journal of Neuropsychopharmacology · 2009 · 199 citations · Full text

, , +10

Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats

Charlotte Klein, Emily A. Karanges, Adena S. Spiro et al. · Psychopharmacology · 2011 · 197 citations · Full text

, , +5

Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice

David Cheng, Adena S. Spiro, Andrew M. Jenner et al. · Journal of Alzheimer s Disease · 2014 · 189 citations

, , +15

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

Dana Boey, Shu Lin, Tim Karl et al. · Diabetologia · 2006 · 187 citations · Full text

, , +13

1–5 of 92